FDA Adverse Event Injury Summary report: N

VIA MICROCATHETER

MDR report key: 4095805 · Received September 2, 2014

Report

Report Number
3008423090-2014-00002
Event Type
Injury
Date Received
September 2, 2014
Date of Event
August 19, 2014
Report Date
September 2, 2014
Manufacturer
SEQUENT MEDICAL, INC.
Product Code
DQY
PMA / PMN Number
K132652
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ACCORDING TO THE DESCRIPTION OF THE CASE, THE WEB IMPLANT WAS IN AN EXCELLENT POSITION, HOWEVER, THE VIA MICROCATHETER WAS DESCRIBED TO ADVANCE, PUSHING THE WEB OUT OF POSITION. BECAUSE THE MICROCATHETER CAUSED THE WEB IMPLANT TO MOVE, LEADING TO AN ANEURYSM PERFORATION, THE EVENT IS BEING REPORTED. HOWEVER, IT IS UNCLEAR WHY THE VIA MICROCATHETER AND SUPPORT CATHETERS ADVANCED. THE WEB ANEURYSM EMBOLIZATION SYSTEM, ALSO USED IN THE CASE, IS NOT AVAILABLE FOR COMMERCIAL SALE IN THE UNITED STATES AND IS CURRENTLY UNDER AN INVESTIGATIONAL DEVICE EXEMPTION, (B)(4).

Description of Event or Problem · 1

A 5 MAX DDC CATHETER WAS PLACED IN THE MID-PORTION OF THE BASILAR ARTERY. THE VIA 27 MICROCATHETER WAS ADVANCED INTO THE DOME OF THE BASILAR ARTERY APEX ANEURYSM OVER A 0.016 HEADLINER FLOPPY 200CM MICROWIRE. THE MICROWIRE WAS REMOVED AND THE 6X3 WEB DL EMBOLIZATION DEVICE WAS ADVANCED THROUGH THE VIA 27 MICROCATHETER AND DEPLOYED IN THE BASILAR APEX UNDER DIRECT FLUOROSCOPIC GUIDANCE. INITIALLY, EXCELLENT POSITIONING AND CONFIRMATION OF THE WEB DEVICE IN THE ANEURYSM WAS SEEN, BUT SUBSEQUENT TO THIS THE VIA CATHETER WAS SEEN TO ADVANCE FORWARD, CREATING A DEEPER RECESS IN THE WEB (PUSHED THE WEB IMPLANT) AND LIKELY PUT PRESSURE ON THE ANEURYSM DOME RESULTING IN PERFORATION. IT WAS ALSO OBSERVED THAT THE ENTIRE SYSTEM INCLUDING THE 5 MAX DDC SYSTEM ADVANCED AS WELL. DSA WAS PERFORMED AFTER DEPLOYMENT OF THE WEB THAT SHOWED A SMALL AMOUNT OF EXTRAVASATION (BLEEDING) AT THE APEX OF THE ANEURYSM. THE WEB DEVICE WAS DETACHED RAPIDLY AND THE VIA 27 CATHETER AND WEB DELIVERY WIRE/SYSTEM WERE REMOVED FROM THE PATIENT. A 7X4 HYPERFORM BALLOON WAS ADVANCED TO THE NECK OF THE ANEURYSM AND INFLATED FOR 3 MINUTES TIME. REPEAT DSA WAS PERFORMED AFTER THE BALLOON WAS DEFLATED AND NO EXTRAVASATION (BLEEDING) WAS VISIBLE AT THAT TIME. A DYNA CT NON-CONTRAST WAS PERFORMED SHOWING A SMALL AMOUNT OF SAH (SUBARACHNOID HEMORRHAGE) IN THE INTERPEDUNCULAR AND PERIMESENCEPHALIC CISTERNS, WITH NO IVH OR HYDROCEPHALUS NOTED. THE PATIENT TOLERATED THE PROCEDURE WELL AND WAS NEUROLOGICALLY INTACT FOLLOWING COMMANDS BRISKLY AFTER THE PROCEDURE. THE PATIENT HAD NO SEQUELAE THE FOLLOWING DAY AND WAS SENT HOME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
532303 VIA MICROCATHETER CONTINUOUS FLUSH CATHETER DQY SEQUENT MEDICAL, INC. VIA-27-154-01 14071501

Patients

Seq Age Sex Outcome Treatment
1 43 YR Hospitalization| L| R